Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back and good morning! It’s the start of the week and that means it’s time for investors to get back into the game. We’re here to help with that as we take a look at the biggest pre-market stock...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks fell broadly Friday, as investors took profits following a flurry of earnings reports, including a blowout quarter from Amazon, and an...
Gainers: Brooklyn ImmunoTherapeutics (BTX) +58%.Regional Health Properties (RHE) +49%.Motus GI Holdings (MOTS) +31%.Bel Fuse (BELFB) +29%.Image Sensing Systems (ISNS) +23%.Farmmi (FAMI) +20%.CryoLife (CRY) +18%.Naked Brand (NAKD) +17%.Laureate Education (LAUR) +14%.Insignia Sys...
Gainers: Willamette Valley Vineyards (WVVI) +55%.Ocular Therapeutix (OCUL) +23%.Galera Therapeutics (GRTX) +23%.JAKKS Pacific (JAKK) +21%.ShiftPixy (PIXY) +19%.1-800-FLOWERS.COM (FLWS) +18%.MEDIROM Healthcare Technologies (MRM) +16%.VEREIT (VER) +16%.Communications Systems (JCS) +15%.Dol...
Gainers: Galera Therapeutics (GRTX) +26%, Ocular Therapeutix (OCUL) +17%, Capricor Therapeutics (CAPR) +15%, AtriCure (ATRC) +12%, Atossa Therapeutics (ATOS) +14%.Losers: Adverum Biotechnologies (ADVM) -60%, Cara Therapeutics (CARA) -44%,...
Adverum Biotechnologies (ADVM) -54% after updates on ADVM-022 diabetic macular edema trial.Cara Therapeutics (CARA) -36% after announces topline results from KARE Phase 2 dose-ranging trial of oral KORSUVA™ in atopic dermatitis patients with moderate-to-severe pruritus.T...
This real-money portfolio was first introduced to the Seeking Alpha community in December 2015. The portfolio outperformed its benchmark in Q1 2021 and is currently outperforming the S&P 500's performance since late-2015. The portfolio was overweight Financials and Industrials...
Gainers: Chembio Diagnostics (CEMI) +61%.AeroCentury (ACY) +59%.Xcel Brands (XELB) +54%.dMY Technology (DMYD) +34%.Performant Financial (PFMT) +33%.Nephros (NEPH) +27%.Nano-X Imaging (NNOX) +26%.Regional Health Properties (RHE) +24%.Leaf Group (LEAF) +21%.Bluegreen Vacatio...
Regional Health Properties, Inc. (NYSE American: RHE) (NYSE American: RHEpA), a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term care, reported results for the year ended December 31, 2020. Bu...
Gainers: Catabasis Pharmaceuticals (CATB) +162%, Novavax (NVAX) +66%, Bellicum Pharmaceuticals (BLCM) +40%, 9 Meters Biopharma (NMTR) +32%, Regional Health Properties (RHE) +9%.Losers: iRhythm Technologies (IRTC) -36%, Lianluo Smart (LLIT) -19...
News, Short Squeeze, Breakout and More Instantly...
Regional Health Properties Inc. Company Name:
RHE Stock Symbol:
NYSE Market:
Regional Health Properties Inc. Website:
Collected 93% of Contractual Rent [ 1] Strong Operator Rent Coverage ATLANTA, GA, April 08, 2024 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company,” “Regional Health,” “we”, “us” or “our”) (NYSE...